Abstract
Stress has a substantial role in formation of psychiatric disorders especially depression. Meanwhile, impairment of the prefrontal cortex (PFC) is connected to the executive and cognitive deficits induced by the stress. Given the involvement of the corticotropin-releasing factor (CRF) in stress-related processes and knowing the fact that PFC hosts a lot of CRF receptors and CRF neurotransmissions, it can worth to look at the CRF as a potential treatment for the regulation of depression disorders induced by stress within PFC region. Here, for the first time we aimed to systematically review the effectiveness of intra-PFC CRF system in the modulation of depression dysfunction caused by the stress in clinical and preclinical models/studies. Qualified researches were combined utilizing a comprehensive search of six databases including Scopus, Pubmed, Web of Science, Sciencedirect, APA PsycNet, and Embase in April 2021 and were evaluated through proper methodological quality assessment tools. Results indicate that PFC has a remarkable role in the modulation for stress-induced depression and intra-PFC CRF receptors agonist and antagonist are very considerable for regulating these types of impairments. Specifically, elevation of both CRF immunoreactivity and gene expression were observed in human studies. In the animal studies, mostly immunoreactivity or excitatory/inhibitory currents of CRF within the PFC regulated depression dysfunction. In conclusion, reviewed studies show a positive attitude toward the CRF system in regulation of the stress-induced depression; however, obviously further investigations are required to get closer to the best treatment.
Graphical Abstract
Prefrontal cortex corticotropin-releasing factor system regulates stress-induced depression. CRFR1, Corticotropin-releasing factor receptor of type1; PFC, Prefrontal cortex; Minus (−) and Plus (+) signs, dysregulation and upregulation, respectively.
Similar content being viewed by others
Data Availability
Data will be made available upon request.
References
Agrawal L, Korkutata M, Vimal SK, Yadav MK, Bhattacharyya S, Shiga T (2020) Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut. Neuropharmacology 166:107969. https://doi.org/10.1016/j.neuropharm.2020.107969
Anisman H, Prakash P, Merali Z, Poulter MO (2007) Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behav Brain Res 181:180–190. https://doi.org/10.1016/j.bbr.2007.04.002
Arborelius L, Owens M, Plotsky P, Nemeroff CB (1999) The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160:1–12. https://doi.org/10.1677/joe.0.1600001
Bale TL, Vale WW (2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525–557. https://doi.org/10.1146/annurev.pharmtox.44.101802.121410
Belleau EL, Treadway MT, Pizzagalli DA (2019) The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology. Biol Psychiat 85:443–453. https://doi.org/10.1016/j.biopsych.2018.09.031
Bibring E (1953) The mechanism of depression
Bijlsma E, Van Leeuwen M, Westphal K, Olivier B, Groenink L (2011) Local repeated corticotropin-releasing factor infusion exacerbates anxiety-and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex. Neuroscience 173:82–92. https://doi.org/10.1016/j.neuroscience.2010.11.026
Brown MR, Fisher LA (1985) Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. Federation Proceedings, pp 243–248
Brown MR, Fisher LA, Webb V, Vale WW, Rivier JE (1985) Corticotropin-releasing factor: a physiologic regulator of adrenal epinephrine secretion. Brain Res 328:355–357. https://doi.org/10.1016/0006-8993(85)91048-0
Canet G, Chevallier N, Zussy C, Desrumaux C, Givalois L (2018) Central role of glucocorticoid receptors in Alzheimer’s disease and depression. Front Neurosci 12:739. https://doi.org/10.3389/fnins.2018.00739
Chen P, Lou S, Huang Z-H, Wang Z, Shan Q-H, Wang Y, Yang Y, Li X, Gong H, Jin Y (2020) Prefrontal cortex corticotropin-releasing factor neurons control behavioral style selection under challenging situations. Neuron. https://doi.org/10.1016/j.neuron.2020.01.033
Csabai D, Wiborg O, Czéh B (2018) Reduced synapse and axon numbers in the prefrontal cortex of rats subjected to a chronic stress model for depression. Front Cell Neurosci 12:24. https://doi.org/10.3389/fncel.2018.00024
Duman RS, Sanacora G, Krystal JH (2019) Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 102:75–90. https://doi.org/10.1016/j.neuron.2019.03.013
Dunn AJ, Berridge CW (1987) Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 27:685–691. https://doi.org/10.1016/0091-3057(87)90195-X
Euston DR, Gruber AJ, McNaughton BL (2012) The role of medial prefrontal cortex in memory and decision making. Neuron 76:1057–1070. https://doi.org/10.1016/j.neuron.2012.12.002
Finlay JM, Jedema HP, Rabinovic AD, Mana MJ, Zigmond MJ, Sved AF (1997) Impact of corticotropin-releasing hormone on extracellular norepinephrine in prefrontal cortex after chronic cold stress. J Neurochem 69:144–150. https://doi.org/10.1046/j.1471-4159.1997.69010144.x
Fu Z, Brouwer M, Kennis M, Williams A, Cuijpers P, Bockting C (2021) Psychological factors for the onset of depression: a meta-analysis of prospective studies. BMJ Open. https://doi.org/10.1136/bmjopen-2021-050129
Girotti M, Adler SM, Bulin SE, Fucich EA, Paredes D, Morilak DA (2018) Prefrontal cortex executive processes affected by stress in health and disease. Prog Neuropsychopharmacol Biol Psychiatry 85:161–179. https://doi.org/10.1016/j.pnpbp.2017.07.004
Gu Z, Pan J, Chen L (2019) MiR-124 suppression in the prefrontal cortex reduces depression-like behavior in mice. Biosci Rep 39:10. https://doi.org/10.1042/BSR20190186
Hammen C (2005) Stress and depression. Annu Rev Clin Psychol 1:293–319
Hammen CL (2015) Stress and depression: old questions, new approaches. Curr Opin Psychol 4:80–85. https://doi.org/10.1016/j.copsyc.2014.12.024
Hankin BL, Young JF, Abela JR, Smolen A, Jenness JL, Gulley LD, Technow JR, Gottlieb AB, Cohen JR, Oppenheimer CW (2015) Depression from childhood into late adolescence: influence of gender, development, genetic susceptibility, and peer stress. J Abnorm Psychol 124:803. https://doi.org/10.1037/abn0000089
Heim C, Binder EB (2012) Current research trends in early life stress and depression: review of human studies on sensitive periods, gene–environment interactions, and epigenetics. Exp Neurol 233:102–111. https://doi.org/10.1016/j.expneurol.2011.10.032
Heinzmann J-M, Kloiber S, Ebling-Mattos G, Bielohuby M, Schmidt MV, Palme R, Holsboer F, Uhr M, Ising M, Touma C (2014) Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: a translational approach. Psychoneuroendocrinology 49:229–243. https://doi.org/10.1016/j.psyneuen.2014.07.008
Heit S, Owens MJ, Plotsky P, Nemeroff CB (1997) REVIEW: corticotropin-releasing factor, stress, and depression. Neuroscientist 3:186–194. https://doi.org/10.1177/107385849700300312
Heshmati M, Christoffel DJ, LeClair K, Cathomas F, Golden SA, Aleyasin H, Turecki G, Friedman AK, Han M-H, Menard C (2020) Depression and social defeat stress are associated with inhibitory synaptic changes in the nucleus accumbens. J Neurosci 40:6228–6233. https://doi.org/10.1523/JNEUROSCI.2568-19.2020
Hooijmans CR, Rovers MM, De Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol 14:1–9. https://doi.org/10.1186/1471-2288-14-43
Huang H, Zhao J, Jiang L, Xie Y, Xia Y, Lv R, Dong L (2015) Paeoniflorin improves menopause depression in ovariectomized rats under chronic unpredictable mild stress. Int J Clin Exp Med 8:5103
Hupalo S, Berridge CW (2016) Working memory impairing actions of corticotropin-releasing factor (CRF) neurotransmission in the prefrontal cortex. Neuropsychopharmacology 41:2733–2740
Hupalo S, Martin AJ, Green RK, Devilbiss DM, Berridge CW (2019) Prefrontal corticotropin-releasing factor (CRF) neurons act locally to modulate frontostriatal cognition and circuit function. J Neurosci 39:2080–2090. https://doi.org/10.1523/JNEUROSCI.2701-18.2019
Jaferi A, Bhatnagar S (2007) Corticotropin-releasing hormone receptors in the medial prefrontal cortex regulate hypothalamic–pituitary–adrenal activity and anxiety-related behavior regardless of prior stress experience. Brain Res 1186:212–223. https://doi.org/10.1016/j.brainres.2007.07.100
Jiang Y, Peng T, Gaur U, Silva M, Little P, Chen Z, Qiu W, Zhang Y, Zheng W (2019) Role of corticotropin releasing factor in the neuroimmune mechanisms of depression: examination of current pharmaceutical and herbal therapies. Front Cell Neurosci 13:290. https://doi.org/10.3389/fncel.2019.00290
Kasckow J, Baker D, Geracioti T Jr (2001) Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides 22:845–851. https://doi.org/10.1016/S0196-9781(01)00399-0
Kaufling J (2019) Alterations and adaptation of ventral tegmental area dopaminergic neurons in animal models of depression. Cell Tissue Res 377:59–71. https://doi.org/10.1007/s00441-019-03007-9
Klerman GL, Weissman MM (1989) Increasing rates of depression. JAMA 261:2229–2235. https://doi.org/10.1001/jama.1989.03420150079041
Langer S, Arbilla S (1990) Presynaptic receptors on peripheral noradrenergic neurons. Ann N Y Acad Sci 604:7–16. https://doi.org/10.1111/j.1749-6632.1990.tb31978.x
Lenz HJ, Raedler A, Greten H, Brown MR (1987) CRF initiates biological actions within the brain that are observed in response to stress. Am J Physiol-Regul Integr Comp Physiol 252:R34–R39. https://doi.org/10.1152/ajpregu.1987.252.1.R34
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34. https://doi.org/10.1016/j.jclinepi.2009.06.006
Liu L, Zhou X, Zhang Y, Liu Y, Yang L, Pu J, Zhu D, Zhou C, Xie P (2016) The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression. Behav Brain Res 305:148–156. https://doi.org/10.1016/j.bbr.2016.03.005
Logan RW, Edgar N, Gillman AG, Hoffman D, Zhu X, McClung CA (2015) Chronic stress induces brain region-specific alterations of molecular rhythms that correlate with depression-like behavior in mice. Biol Psychiat 78:249–258. https://doi.org/10.1016/j.biopsych.2015.01.011
Ma L-L, Wang Y-Y, Yang Z-H, Huang D, Weng H, Zeng X-T (2020) Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res 7:1–11. https://doi.org/10.1186/s40779-020-00238-8
McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF, DeChant HK, Ryden J, Derogatis LR, Bass EB (1997) Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA 277:1362–1368. https://doi.org/10.1001/jama.1997.03540410040028
McKlveen JM, Morano RL, Fitzgerald M, Zoubovsky S, Cassella SN, Scheimann JR, Ghosal S, Mahbod P, Packard BA, Myers B (2016) Chronic stress increases prefrontal inhibition: a mechanism for stress-induced prefrontal dysfunction. Biol Psychiat 80:754–764. https://doi.org/10.1016/j.biopsych.2016.03.2101
Melón LC, Maguire J (2016) GABAergic regulation of the HPA and HPG axes and the impact of stress on reproductive function. J Steroid Biochem Mol Biol 160:196–203. https://doi.org/10.1016/j.jsbmb.2015.11.019
Meng Q-Y, Chen X-N, Tong D-L, Zhou J-N (2011) Stress and glucocorticoids regulated corticotropin releasing factor in rat prefrontal cortex. Mol Cell Endocrinol 342:54–63. https://doi.org/10.1016/j.mce.2011.05.035
Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Bédard T, Anisman H (2006) Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol Psychiat 59:594–602
Mullen PE, Martin JL, Anderson JC, Romans SE, Herbison GP (1996) The long-term impact of the physical, emotional, and sexual abuse of children: a community study. Child Abuse Negl 20:7–21. https://doi.org/10.1016/0145-2134(95)00112-3
Nasca C, Bigio B, Zelli D, de Angelis P, Lau T, Okamoto M, Soya H, Ni J, Brichta L, Greengard P (2017) Role of the astroglial glutamate exchanger xCT in ventral hippocampus in resilience to stress. Neuron. https://doi.org/10.1016/j.neuron.2017.09.020
Petrozzi BP, Blecker C, Neumann E, Sammer G (2020) The secret behind peripheral inflammation and depression. Hypothalamus. https://doi.org/10.21203/rs.3.rs-53606/v1
Qi X-R, Kamphuis W, Wang S, Wang Q, Lucassen PJ, Zhou J-N, Swaab DF (2013) Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology 38:863–870. https://doi.org/10.1016/j.psyneuen.2012.09.014
Raone A, Cassanelli A, Scheggi S, Rauggi R, Danielli B, De Montis M (2007) Hypothalamus–pituitary–adrenal modifications consequent to chronic stress exposure in an experimental model of depression in rats. Neuroscience 146:1734–1742. https://doi.org/10.1016/j.neuroscience.2007.03.027
Robinson SL, Perez-Heydrich CA, Thiele TE (2019) Corticotropin releasing factor type 1 and 2 receptor signaling in the medial prefrontal cortex modulates Binge-like ethanol consumption in C57BL/6J mice. Brain Sci 9:171. https://doi.org/10.3390/brainsci9070171
Roddy DW, Farrell C, Doolin K, Roman E, Tozzi L, Frodl T, O’Keane V, O’Hanlon E (2019) The hippocampus in depression: more than the sum of its parts? Advanced hippocampal substructure segmentation in depression. Biol Psychiat 85:487–497. https://doi.org/10.1016/j.biopsych.2018.08.021
Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL (2018) Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology 142:263–269. https://doi.org/10.1016/j.neuropharm.2017.12.041
Rusconi F, Battaglioli E (2018) Acute stress-induced epigenetic modulations and their potential protective role toward depression. Front Mol Neurosci 11:184. https://doi.org/10.3389/fnmol.2018.00184
Saleh A, Potter GG, McQuoid DR, Boyd B, Turner R, MacFall JR, Taylor WD (2017) Effects of early life stress on depression, cognitive performance, and brain morphology. Psychol Med 47:171. https://doi.org/10.1017/S0033291716002403
Sampath D, Sathyanesan M, Newton SS (2017) Cognitive dysfunction in major depression and Alzheimer’s disease is associated with hippocampal–prefrontal cortex dysconnectivity. Neuropsychiatr Dis Treat 13:1509
Schreiber AL, Lu Y-L, Baynes BB, Richardson HN, Gilpin NW (2017) Corticotropin-releasing factor in ventromedial prefrontal cortex mediates avoidance of a traumatic stress-paired context. Neuropharmacology 113:323–330. https://doi.org/10.1016/j.neuropharm.2016.05.008
Sedaghat K, Yousefian Z, Vafaei AA, Rashidy-Pour A, Parsaei H, Khaleghian A, Choobdar S (2019) Mesolimbic dopamine system and its modulation by vitamin D in a chronic mild stress model of depression in the rat. Behav Brain Res 356:156–169. https://doi.org/10.1016/j.bbr.2018.08.020
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg 73:712–716. https://doi.org/10.1046/j.1445-2197.2003.02748.x
Steinberg R, Alonso R, Griebel G, Bert L, Jung M, Oury-Donat F, Poncelet M, Gueudet C, Desvignes C, Le Fur G (2001) Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function. J Pharmacol Exp Ther 299:449–458
Stringaris A (2017) What is depression? Wiley Online Library
Thul TA, Corwin EJ, Carlson NS, Brennan PA, Young LJ (2020) Oxytocin and postpartum depression: a systematic review. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2020.104793
Underwood MD, Kassir SA, Bakalian MJ, Galfalvy H, Dwork AJ, Mann JJ, Arango V (2018) Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity. Transl Psychiatry 8:1–15. https://doi.org/10.1038/s41398-018-0309-1
Uribe-Mariño A, Gassen NC, Wiesbeck MF, Balsevich G, Santarelli S, Solfrank B, Dournes C, Fries GR, Masana M, Labermeier C (2016) Prefrontal cortex corticotropin-releasing factor receptor 1 conveys acute stress-induced executive dysfunction. Biol Psychiat 80:743–753. https://doi.org/10.1016/j.biopsych.2016.03.2106
Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213:1394–1397
Van Praag H (2004) Can stress cause depression? Prog Neuropsychopharmacol Biol Psychiatry 28:891–907. https://doi.org/10.1016/j.pnpbp.2004.05.031
Van Praag HM, de Kloet ER, Van Os J (2004) Stress, the brain and depression. Cambridge University Press
Vidrascu EM, Robertson MM (2021) Inhibitory corticotropin-releasing factor neurons in the dorsomedial prefrontal cortex promote stress-resilient behavior in male rodents. J Neurophysiol 125:533–536
Wang S, Wang C, Yu Z, Wu C, Peng D, Liu X, Liu Y, Yang Y, Guo P, Wei J (2018) Agarwood essential oil ameliorates restrain stress-induced anxiety and depression by inhibiting HPA axis hyperactivity. Int J Mol Sci 19:3468. https://doi.org/10.3390/ijms19113468
Wang X-Q, Zhang L, Xia Z-Y, Chen J-Y, Fang Y, Ding Y-Q (2021) PTEN in prefrontal cortex is essential in regulating depression-like behaviors in mice. Transl Psychiatry 11:1–12. https://doi.org/10.1038/s41398-021-01312-y
Warner V, Weissman MM, Mufson L, Wickramaratne PJ (1999) Grandparents, parents, and grandchildren at high risk for depression: a three-generation study. J Am Acad Child Adolesc Psychiatry 38:289–296. https://doi.org/10.1097/00004583-199903000-00016
Weissman MM, Warner V, Wickramaratne P, Moreau D, Olfson M (1997) Offspring of depressed parents: 10 years later. Arch Gen Psychiatry 54:932–940. https://doi.org/10.1001/archpsyc.1997.01830220054009
Wood SK, Walker HE, Valentino RJ, Bhatnagar S (2010) Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor. Endocrinology 151:1795–1805. https://doi.org/10.1210/en.2009-1026
Yang X-D, Liao X-M, Uribe-Marino A, Liu R, Xie X-M, Jia J, Su Y-A, Li J-T, Schmidt MV, Wang X-D (2015) Stress during a critical postnatal period induces region-specific structural abnormalities and dysfunction of the prefrontal cortex via CRF 1. Neuropsychopharmacology 40:1203–1215. https://doi.org/10.1038/npp.2014.304
Young EA, Abelson JL, Curtis GC, Nesse RM (1997) Childhood adversity and vulnerability to mood and anxiety disorders. Depress Anxiety 5:66–72. https://doi.org/10.1002/(SICI)1520-6394(1997)5:2%3C66::AID-DA2%3E3.0.CO;2-3
Zlotnick C, Ryan CE, Miller IW, Keitner GI (1995) Childhood abuse and recovery from major depression. Child Abuse Negl 19:1513–1516. https://doi.org/10.1016/0145-2134(95)00098-6
Acknowledgements
This work was supported by Major Scientific and Technological Program of China (2021ZD0203802), the National Natural Science Foundation of China (32071028), the Natural Science Foundation of Beijing Municipality (5202023), CAS-VPST Silk Road Science Fund 2021 (GJHZ202129), and the Iran National Science Foundation (No. 99007925). The authors also acknowledge support from 2017 CAS-TWAS President’s Fellowship for international Ph.D. students, awarded jointly by the Chinese Academy of Sciences and The World Academy of Sciences. We greatly appreciate the excellent work of the technical support staff Amir Asadollahi at the Laser and Plasma Research Institute, Shahid Beheshti University, Tehran, Iran and Behzad Golshaei at department of Biomedical Engineering, Duke University, Durham, NC.
Author information
Authors and Affiliations
Contributions
J.L. and A.H. were responsible for the study concept and design. M.M.A. and M.F. contributed to searching all databases and evaluating through proper methodological quality assessment tools. M.M.A drafted the manuscript. J.L., S.H., and F.S. provided critical revision of the manuscript for important intellectual content. All authors critically reviewed content and approved final version for publication.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Alizamini, M.M., Fattahi, M., Sayehmiri, F. et al. Regulatory Role of PFC Corticotropin-Releasing Factor System in Stress-Associated Depression Disorders: A Systematic Review. Cell Mol Neurobiol 43, 1785–1797 (2023). https://doi.org/10.1007/s10571-022-01289-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-022-01289-2